Merck & Co., Inc. cotiza a 145.60 USD y tiene una capitalización bursátil de $359.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvay…
| Métrica | MRK | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 74.8% | 57.0% | +17.8% |
| Operating Margin | — | -38.6% | — |
| Net Margin | 28.1% | -33.6% | +61.6% |
| FCF Margin | 19.0% | -13.9% | +32.9% |
| ROE | 34.7% | -40.4% | +75.1% |
| ROA | 13.3% | -32.0% | +45.3% |
| Current Ratio | 1.54 | 2.84 | -1.30 |
| Debt / Equity | 0.89 | 0.28 | +0.61 |